文献速递免疫规划妇幼与学校卫生

四价流感疫苗在孕妇和婴儿中的有效性:2018-2019年研究

Effectiveness of quadrivalent influenza vaccine in pregnant women and infants, 2018-2019.
PubMed 文献 · Vaccine · 2020-05-08

该前瞻性研究在2018-2019年流感季评估四价灭活流感疫苗(QIV)在孕妇及其婴儿中的有效性。疫苗对孕妇和婴儿实验室确诊流感的有效性分别为72%和64.5%,支持WHO推荐孕妇接种流感疫苗。

要点

  • 孕妇接种QIV可降低自身实验室确诊流感风险(2.1% vs 7.5%,OR=3.6)。
  • 疫苗对孕妇和婴儿实验室确诊流感的有效性分别为72%和64.5%。

核心结论

  • 孕妇接种四价流感疫苗可降低自身及婴儿实验室确诊流感的风险。
  • 研究结果强烈支持世界卫生组织关于孕妇接种流感疫苗的建议。

研究设计与样本

  • 前瞻性研究,2018-2019年流感季在雅典一家妇产医院招募孕妇。
  • 共研究423名孕妇和446名婴儿,每周电话随访,对出现流感样疾病(ILI)者进行PCR检测。

主要发现

  • Cox回归分析显示,QIV接种与孕妇实验室确诊流感、ILI、就医和住院概率降低显著相关。
  • Cox回归分析显示,QIV接种与婴儿实验室确诊流感、就医和抗生素处方概率降低显著相关。
  • QIV对实验室确诊流感的有效性在孕妇中为72%,在婴儿中为64.5%。

临床怎么用

  • 建议孕妇接种四价流感疫苗以降低自身和婴儿的流感风险。
  • 符合WHO推荐,应将孕妇流感疫苗接种纳入常规预防保健。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Influenza is associated with an increased risk for serious illness, hospitalization and/or death in pregnant women and young infants. We prospectively studied the effectiveness of a quadrivalent inactivated influenza vaccine (QIV) in pregnant women and their infants during the 2018-2019 influenza season. A QIV was offered to pregnant women cared in a maternity hospital in Athens. Women were contacted weekly by telephone during the influenza season and PCR test was offered to women or infants who developed influenza-like illness (ILI). We studied 423 pregnant women and 446 infants. Unvaccinated pregnant women had a 7.5% probability to develop laboratory-confirmed influenza compared to 2.1% among vaccinated women (Odds ratio: 3.6; confidence intervals: 1.14-11.34, p-value = 0.029). Infants whose mothers were not vaccinated had a 7.9% probability to develop laboratory-confirmed influenza compared to 2.8% among infants of vaccinated mothers (Odds ratio = 2.849, confidence intervals: 0.892-9.102, p-value = 0.053). Cox regression analyses showed that QIV vaccination was significantly associated with a decreased probability for laboratory-confirmed influenza, ILI, healthcare seeking and hospitalization among pregnant women and a decreased probability for laboratory-confirmed influenza, healthcare seeking and prescription of antibiotics among infants. The effectiveness of QIV against laboratory-confirmed influenza was 72% among pregnant women and 64.5% among infants during the 2018-2019 influenza season. Vaccination of pregnant women with the QIV was associated with a lower risk for laboratory-confirmed influenza for them and their infants during the influenza season. Our findings strongly support the World Health Organization recommendations for vaccinating pregnant women against influenza.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Maltezou HC, Asimakopoulos G, Stavrou S, et al. Effectiveness of quadrivalent influenza vaccine in pregnant women and infants, 2018-2019. Vaccine. 2020. PMID: 32402751. doi:10.1016/j.vaccine.2020.04.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。